First Test Batches of Russia’s AI assisted Cancer Vaccine Have Been Created
Russian scientists have produced the first three test batches of a newly developed cancer vaccine at the Gamaleya Institute in Moscow. This new "vaccine" is said to be a breakthrough drug. It's an artificial intelligence-assisted, mRNA-based vaccine designed to target malignant tumors using the patient’s own genetic data.